Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Gait clinical trials

4 of 6 indexed Gait trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Gait: 6 US clinical trials tracked, 4 recruiting.

Gait is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is University of North Carolina, Greensboro, running 1 of these trials.

Enrollment posture brief

Registry condition gait

OPEN 4 | RECR 67% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Gait (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Gait

Gait lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gait on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gait is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gait research.

    University of North Carolina, Greensboro accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Gait trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Gait research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Gait records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Group exercise program Behavioral
1 trials
Ballroom Dance Other
1 trials
Sensor-enabled Athletic X Ankle Brace (sXAB) Device
1 trials
Sham real-time gait biofeedback Behavioral
1 trials
Real-time gait biofeedback Behavioral
1 trials
NNP-LE Device
1 trials
Peripheral electrical stimulation paired with cortical magnetic stimulation pulses Device
1 trials
Functional electrical stimulation (FES) Device
1 trials

US sites by state

Facility locations filed on Gait trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Wisconsin 1 trials
Ohio 1 trials
Indiana 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gait page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gait condition card totals 6 registered trials; most-linked intervention Group exercise program; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.